WallStreetZenWallStreetZen

NASDAQ: AVXL
Anavex Life Sciences Corp Stock Ownership - Who owns Anavex Life Sciences?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Anavex Life Sciences Corp insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Christopher U. MisslingPresident and CEO2024-03-2873,380$5.11
$374.97kSell
Christopher U. MisslingPresident and CEO2024-03-2873,380$1.32
$96.86kBuy
Christopher U. MisslingPresident and CEO2023-06-29232,000$1.60
$371.20kBuy
Christopher U. MisslingPresident and CEO2023-06-28268,000$7.98
$2.14MSell
Christopher U. MisslingPresident and CEO2023-06-28268,000$1.60
$428.80kBuy

1 of 1

AVXL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AVXL insiders and whales buy or sell their stock.

AVXL Shareholders

What type of owners hold Anavex Life Sciences Corp stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc8.12%6,671,075$22.95MInstitution
Vanguard Group Inc5.31%4,360,648$15.00MInstitution
State Street Corp4.44%3,642,702$12.53MInstitution
Geode Capital Management LLC2.03%1,665,364$5.73MInstitution
Athanasios Skarpelos1.59%1,306,458$4.49MInsider
Christopher U. Missling1.52%1,250,210$4.30MInsider
George Kalkanis1.10%900,000$3.10MInsider
Nwam LLC0.97%798,293$2.75MInstitution
Northern Trust Corp0.90%741,425$2.55MInstitution
Susquehanna International Group LLP0.88%721,353$2.48MInstitution

1 of 3

AVXL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVXL31.49%5.04%Net BuyingNet Buying
MGX0.00%32.96%Net BuyingNet Buying
LYRA70.88%14.48%Net Buying
RAPT66.33%33.67%Net Selling
AKBA26.15%8.85%Net SellingNet Selling
View Top Biotech Stocks

Anavex Life Sciences Stock Ownership FAQ

Who owns Anavex Life Sciences?

Anavex Life Sciences (NASDAQ: AVXL) is owned by 31.49% institutional shareholders, 5.04% Anavex Life Sciences insiders, and 63.48% retail investors. Athanasios Skarpelos is the largest individual Anavex Life Sciences shareholder, owning 1.31M shares representing 1.59% of the company. Athanasios Skarpelos's Anavex Life Sciences shares are currently valued at $4.49M.

If you're new to stock investing, here's how to buy Anavex Life Sciences stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.